Plenary Session – Update on Assessing Patient and Site Receptivity in Direct-to-Patient Clinical Supply Solutions

GCSG sponsored a study on Assessing Patient and Site Receptivity in Direct-to-Patient Clinical Supply Solutions which was conducted by the Tufts Center for the Study of Drug Development. We are pleased to share that the initial analysis of the patient perspectives is complete, and overall, patients have very positive views of Direct-to-Patient delivery of investigational product. The study has also identified opportunities to improve the patient experience. We are looking forward to the results of the site perspectives and sharing the full results of the study with the GCSG community in early 2025.